Paratus Sciences

Paratus Sciences
Biotech startup leveraging bat biology for novel therapeutics in immunology and cardiometabolic diseases.
About
What does Paratus Sciences do?
Paratus Sciences is a biotechnology company that develops novel therapeutics by analyzing the unique evolutionary adaptations of bats. Their platform merges genomics, multi-omics, and informatics to identify therapeutic targets, initially focusing on immunological and cardiometabolic conditions. The company aims to translate insights from bat biology into groundbreaking treatments for diseases with significant unmet medical needs.
What is Paratus Sciences's revenue?
StartupHub estimates Paratus Sciences's annual revenue at $4.2M (range $3.0M to $9.5M, 65% confidence), based on comparable companies in the sector.
Where is Paratus Sciences headquartered?
Paratus Sciences is headquartered in New York, United States.
When was Paratus Sciences founded?
Paratus Sciences was founded in 2021.
What industry does Paratus Sciences operate in?
Paratus Sciences operates in Biotech, Drug Discovery, Genomics, Informatics, Immunology, Cardiometabolic Diseases.
How many employees does Paratus Sciences have?
Paratus Sciences has approximately 19 people on record.
No comments yet. Be the first to share your take.
